Chinas Coal Strategy Powering the Next Phase of Energy Dominance Pine Labs Reports Turnaround Rs 59 Crore Net Profit in Q4 on 17 Revenue Growth From Service to Skilled Trades The Untapped Pipeline Reshaping Americas Labor Market Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Project Innio Targets 203 Billion Valuation in US IPO With Advent and ADIA Backing Automated Garment Manufacturing Could Reshape Global Apparel Supply Chains CTXR Q4 2025 Earnings EPS Misses Estimates as PreRevenue Biotech Reports Wider Loss EFSCP Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Higher CW Q1 2026 Earnings EPS Beat Driven by Operational Efficiency Infinity Natural Resources Inc INR Q1 2026 Earnings Massive Earnings Beat Amid Cost Improvements GTES Q1 2026 Earnings EPS Beats Estimates Revenue Details Limited First Financial Bancorp FFBC Q1 2026 Earnings Earnings Beat Expectations as Core Operations Hold Steady BioHarvest Sciences Inc BHST Gains 105 While Testing Key Resistance at 405 Celsius Holdings CELH Surges Over 10 Can Momentum Sustain Above Key Levels Bluerock Acquisition Corp BLRK Holds Steady as Consolidation Continues Near Key Levels Japer Therapeutics Warrants JSPRW Hold Steady at 001 as Traders Eye Catalysts Southwest Gas Holdings Inc SWX Rises 115 as Utility Stocks Hold Steady Near Key Resistance Power to the People How Balcony Solar Could Help Ease Rising US Utility Costs Gaza Flotilla Detainee Allegations Could Impact Israels International Relations and Economic Stability Amazon UK Boss Says Education System Fails to Prepare Youth for Workforce Calls for Shift in Blame Indian Equity Markets Edge Lower Mid and SmallCaps Outperform Surging Gas Prices Disproportionately Burden LowIncome Households New York Fed Study Reveals Indias Renewable Energy Sector Faces Grid Integration Headwinds in Q1 2026 Despite 275 GW Capacity Milestone South Koreas Deputy PM Warns AI Wealth Concentration Risks Worsening Inequality Amid Samsung Labor Strife BGMS Q3 2024 Earnings Significant EPS Beat Tempered by Revenue Uncertainty MoonLake Immunotherapeutics MLTX Shows Modest Uptick Testing Key Resistance